Earnings Feed
Start Free
Anika Therapeutics, Inc.·4

Jun 5, 4:10 PM ET

Griffin Stephen D. 4

4 · Anika Therapeutics, Inc. · Filed Jun 5, 2024

Insider Transaction Report

Form 4
Period: 2024-06-03
Anika Therapeutics, Inc.ANIK
Griffin Stephen D.
DirectorPresident and CEO
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-06-03+96,525→ 96,525 total
    Exercise: $29.35Exp: 2034-06-03→ Common Stock (96,525 underlying)
  • Award

    Restricted Stock Unit

    2024-06-03+38,520→ 38,520 total
    Exercise: $0.00→ Common Stock (38,520 underlying)
Footnotes (3)
  • [F1]Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning June 3, 2025.
  • [F2]Represents a 10% premium above the closing price of Anika's common stock on the date of grant.
  • [F3]The premium priced stock options vest in three equal annual installments beginning on June 3, 2025.

Documents

1 file
  • 4
    ownership.xmlPrimary